Frequently Asked Questions (FAQ's) about Juv é derm
What is JUVÉDERMT?
JuvédermT is the only HA filler with FDA approval to last up to one year.* Ask your physician how you can get long-lasting results with JuvédermT . JuvédermT injectable gel is a "next-generation" smooth consistency gel dermal filler that helps to instantly restore your skin's volume and smooth away facial wrinkles and folds like your "smile lines" or "parentheses" (nasolabial folds-the creases that run from the bottom of your nose to the corners of your mouth). JuvédermT comes in two formulations- JuvédermT Ultra and JuvédermT Ultra Plus.
* JuvédermT is indicated for injection into the mid to deep dermis for correction of moderate to severe facial wrinkles and folds (such as nasolabial folds).
What does JUVÉDERMT do?
JuvédermT injectable gel temporarily adds volume to facial tissue and restores a smoother appearance to the face.
What is JUVÉDERMT indicated for?
JuvédermT Ultra and JuvédermT Ultra Plus injectable gels are indicated for injection into the mid to deep dermis (below the outer layer of skin) for the correction of moderate to severe facial wrinkles and folds, such as nasolabial folds (the creases running from the bottom of your nose to the corners of your mouth, aka smile lines or parentheses).
Why does JUVÉDERMT come in two formulations?
JuvédermT injectable gel is available in two formulations to allow your healthcare professional to tailor treatment to your unique needs. JuvédermT Ultra provides versatility in contouring and volumizing facial wrinkles and folds. JuvédermT Ultra Plus is a more robust formulation for volumizing and correcting deeper folds and wrinkles.
What makes JUVÉDERMT different from other dermal fillers?
JUVÉDERMT is the ONLY hyaluronic acid (HA) filler FDA approved to last up to 1 year. * It also works to create a smooth consistency gel that flows easily into the skin and provides a smooth, natural look and feel. All other hyaluronic acid dermal fillers currently on the market are made of granular consistency gels. And, JuvédermT is the first hyaluronic acid dermal filler that has demonstrated its safety and effectiveness in persons of color.
* JuvédermT is indicated for injection into the mid to deep dermis for correction of moderate to severe facial wrinkles and folds (such as nasolabial folds).
How is JUVÉDERMT injectable gel used in treatment?
At NiceLookNShape, we ease JuvédermT injectable gel into the skin using a fine needle to temporarily fill in and augment the treatment area and smooth moderate to severe facial wrinkles and folds such as "smile lines" or "parentheses" (nasolabial folds) and "marionette lines" (oral commissures). JuvédermT temporarily adds volume to the skin and may give the appearance of a smoother surface.
What will treatment with JUVÉDERMT injectable gel accomplish?
JuvédermT injectable gel will help to smooth moderate to severe facial wrinkles and folds. Most patients need one treatment to achieve optimal wrinkle smoothing. And one treatment could smooth your lines and wrinkles for up to 1 year. Ask your doctor what you should expect from your initial treatment and when they would recommend rescheduling another appointment.
Does the correction last forever?
No. Correction is temporary; therefore, touch-up injections as well as repeat injections are usually needed to maintain optimal corrections.
What are the possible side effects of JUVÉDERMT injectable gel?
Most side effects are mild or moderate in nature, and their duration is short lasting (7 days or less). The most common side effects include, but are not limited to, temporary injections site reactions such as redness, pain/tenderness, firmness, swelling, lumps/bumps, bruising, itching, and discoloration. As with all skin injection procedures there is a risk of infection.
Can people with different skin tones/colors be treated with JUVÉDERMT?
Yes. In fact, JuvédermT injectable gel is the first FDA-approved hyaluronic acid dermal filler that has proven its safety and effectiveness in persons of color. Studies with JuvédermT showed no increased risk of hyperpigmentation or hypertrophic scarring in patients of color. |
